Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 9/20 | 0.34 |
| ▸ | RAB9A | P51151 | 4/20 | 0.34 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.34 |
| ▸ | NOS3 | P29474 | 1/20 | 0.33 |
| ▸ | NOS1 | P29475 | 1/20 | 0.33 |
| ▸ | NOS2 | P35228 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 8/20 | 0.33 |
| ▸ | ACHE | P22303 | 3/20 | 0.33 |
| ▸ | POLB | P06746 | 3/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.33 |
| ▸ | PSMD14 | O00487 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 7/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.33 |
| ▸ | USP2 | O75604 | 1/20 | 0.33 |
| ▸ | RECQL | P46063 | 1/20 | 0.33 |
| ▸ | BLM | P54132 | 1/20 | 0.33 |
| ▸ | SAE1 | Q9UBE0 | 1/20 | 0.33 |
| ▸ | UBA2 | Q9UBT2 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL651596 | 0.88 | NOS3 (0.34) | MAPTRAB9AHCRTR1NOS3NOS1 | |
| SCHEMBL10176461 | 0.82 | ABL1 (0.35) | MAPTRAB9AHCRTR1NOS3NOS1 | |
| SCHEMBL651474 | 0.82 | NOS3 (0.35) | MAPTRAB9AHCRTR1NOS3NOS1 | |
| SCHEMBL651037 | 0.81 | NOS3 (0.36) | MAPTRAB9AHCRTR1NOS3NOS1 | |
| SCHEMBL10176418 | 0.80 | MAPK1 (0.37) | MAPTRAB9AHCRTR1NOS3NOS1 | |
| SCHEMBL650363 | 0.78 | HTR6 (0.33) | MAPTRAB9AHCRTR1NOS3NOS1 | |
| SCHEMBL649047 | 0.74 | MAPT (0.41) | MAPTRAB9AHCRTR1KMT2APOLB | |
| SCHEMBL10176421 | 0.74 | NOS3 (0.36) | MAPTRAB9AHCRTR1NOS3NOS1 | |
| SCHEMBL10176423 | 0.73 | NOS3 (0.38) | MAPTRAB9AHCRTR1NOS3NOS1 | |
| SCHEMBL652184 | 0.71 | MAPT (0.42) | MAPTRAB9AKMT2APOLBMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8119812-B2 | Thiazolidinone derivative | SBI BIOTECH CO., LTD. (JP) | 2012-02-21 | — | — | US | disclosed |
| US-8119586-B2 | Composition containing an esterified substituted benzene sulfonate | THE PROCTER AND GAMBLE COMPANY (US) | 2012-02-21 | — | — | US | disclosed |
| US-20110190299-A1 | THIAZOLIDINONE DERIVATIVE | SBI BIOTECH CO., LTD. (JP) | 2011-08-04 | — | — | US | disclosed |
| US-20110112317-A1 | Composition Containing an Esterified Substituted Benzene Sulfonate | SCHEIBEL JEFFREY JOHN | 2011-05-12 | — | — | US | disclosed |
| EP-1951857-B1 | COMPOSITION CONTAINING AN ESTERIFIED SUBSTITUTED BENZENE SULFONATE | PROCTER & GAMBLE (US) | 2011-02-23 | — | — | EP | disclosed |
| US-7892362-B2 | Composition containing an esterified substituted benzene sulfonate | THE PROCTER & GAMBLE COMPANY (US) | 2011-02-22 | — | — | US | disclosed |
| US-20100024135-A1 | COMPOSITION CONTAINING AN ESTERIFIED SUBSTITUTED BENZENE SULFONATE | THE PROCTER & GAMBLE COMPANY | 2010-02-04 | — | — | US | disclosed |
| US-7585376-B2 | Composition containing an esterified substituted benzene sulfonate | THE PROCTER & GAMBLE COMPANY (US) | 2009-09-08 | — | — | US | disclosed |
| US-20070105742-A1 | Composition containing an esterified substituted benzene sulfonate | PROCTER & GAMBLE COMPANY, THE | 2007-05-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110190299-A1 | THIAZOLIDINONE DERIVATIVE | CDC7, CDK17, CDCA2 | MAPT 3657/4885RAB9A 3157/4885HCRTR1 4349/4885 |
| US-20110112317-A1 | Composition Containing an Esterified Substituted Benzene Sulfonate | HDHD5, STS, PRDX4 | MAPT 2658/4885RAB9A 4700/4885HCRTR1 4331/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.